Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa. [electronic resource]
- PloS one Sep 2010
- e12873 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1932-6203
10.1371/journal.pone.0012873 doi
AIDS Vaccines--adverse effects Adenoviridae--genetics Adolescent Adult Antibodies, Viral--immunology Double-Blind Method Drug-Related Side Effects and Adverse Reactions Genetic Vectors--adverse effects HIV Infections--immunology HIV-1--classification Humans Immunization, Secondary Male Middle Aged Vaccines, DNA--adverse effects Young Adult gag Gene Products, Human Immunodeficiency Virus--adverse effects pol Gene Products, Human Immunodeficiency Virus--adverse effects